Getinge plans to launch the Vasoview Hemopro 3 in the US during the third quarter of this year. Credit: Getinge.

Medical technology company Getinge has obtained the US Food and Drug Administration’s (FDA) 510(k) clearance for its Vasoview Hemopro 3, an endoscopic vessel harvesting (EVH) solution for cardiovascular surgery.

The development of Vasoview Hemopro 3 is the result of extensive market research and advisory boards carried out in partnership with clinicians in the EVH field.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The product is designed to improve procedural efficiency and patient outcomes, with features such as enhanced smoke evacuation, regulated energy control, an ergonomic game controller-style handle, and an integrated cable.

Getinge plans to launch Vasoview Hemopro 3 in the US during the third quarter of 2024, with registrations in other key markets currently in progress.

Getinge president for acute care therapies Elin Frostehav said: “EVH is a therapy significantly helping patients towards faster recovery by minimising surgical trauma and reducing post-operative pain. By offering solutions together with extensive training, we aim to continue help facilitating the widespread adoption of this essential therapy.

See Also:

“The new generation of Vasoview – Hemopro 3 – symbolises our dedication to elevating healthcare standards together with our customers.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In a separate announcement, Getinge has launched the Corin OR table and Ezea surgical light at the Association of periOperative Registered Nurses (AORN) conference, being held in Nashville, Tennessee, from 10 to 12 March.

The Maquet Corin OR table is a smart mobile surgical table. It features advanced feedback lighting, intuitive controls, collision detection, overload detection, and tipping prevention, to enhance safety.

Designed to be user-friendly, the Maquet Ezea light features include external handles and a lightweight design. This allows for efficient manoeuvring and quick setup. 

Getinge North America surgical workflows commercial operations director Stefan Runnström said: “Hospital systems nationwide are experiencing a need for strategic and proven-effective solutions that ensure the highest levels of operational efficiency, as well as the proper care and safety of patients.

“The Corin OR table and Ezea surgical light are designed to address challenges in OR management, allowing physicians to devote their full attention to patient care while ensuring effective risk management.”